Latest Cancer treatments Stories
NCI study to investigate whether third generation CAR T Cells can be eliminated if they become harmful HOUSTON, March 17, 2014 /PRNewswire/ -- Bellicum Pharmaceuticals, Inc.
HOUSTON, March 17, 2014 /PRNewswire-USNewswire/ -- The University of Texas MD Anderson Cancer Center and MedImmune, the global biologics research and development arm of AstraZeneca, will collaborate
Researchers say resveratrol slows cancer growth without the toxicity and irritation of chemotherapy. Raleigh, NC (PRWEB) March 16, 2014 A new report
ORLANDO, Fla., March 12, 2014 /PRNewswire/ -- TNI BioTech, Inc.
Global breast cancer survey demonstrates physicians generally prefer standard of care chemotherapy as compared to newly approved targeted therapies NEW YORK, March 11, 2014 /PRNewswire/
SYDNEY, March 7, 2014 /PRNewswire/ -- Viralytics Limited (ASX:VLA, OTC:VRACY) will present at two prominent U.S.
A Ludwig Cancer Research study suggests that the clinical efficacy of checkpoint blockade, a powerful new strategy to harness the immune response to treat cancers, might be dramatically improved if combined with oncolytic virotherapy, an investigational intervention that employs viruses to destroy tumors.
Many breast cancer survivors experience fatigue and other debilitating symptoms that persist months to years after their course of treatment has ended.
Researchers at the Translational Genomics Research Institute (TGen) have discovered a protein, Mcl-1, that helps enable one of the most common and deadly types of cancer to survive radiation and drug treatments.
Researchers say reduced white blood cell count with chemotherapy could be corrected with appropriate medication. Raleigh, NC (PRWEB) March 03, 2014 Researchers
- In the month which preceded the present; in the last month, as distinguished from the current or present month and all others.
More Images (3 images) »